


Editor-in-Chief: Mohammad Abdollahi
ISSN: 2008-2231 (electronic version)
Journal no. 40199
As an international journal, DARU Journal of Pharmaceutical Sciences considers outstanding studies from basic research to clinical investigations as original articles, systematic reviews, meta-analyses, general reviews, mini-reviews, short communications, and editorials from the global scientific community. Therefore, the journal welcomes submissions from all over the world.
Related subjects » Biochemistry - Pharmacology & Toxicology
Journal Citation Reports®
Science Citation Index Expanded (SciSearch), Journal Citation Reports/Science Edition, Medline, PubMedCentral, SCOPUS, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, BIOSIS, CAB Abstracts, CNKI, Dimensions, EBSCO Academic Search, EBSCO Biomedical Reference Collection, EBSCO CINAHL, EBSCO Discovery Service, EBSCO One Belt, One Road Reference Source, EBSCO STM Source, Gale, Institute of Scientific and Technical Information of China, Japanese Science and Technology Agency (JST), Meta, Naver, OCLC WorldCat Discovery Service, Product.Indexing: ??? INDASV928 ???, ProQuest Central, ProQuest Health & Medical Collection, ProQuest Health Research Premium Collection, ProQuest Medical Database, ProQuest Middle East & Africa Database, ProQuest Research Library, ProQuest-ExLibris Primo, ProQuest-ExLibris Summon, Reaxys, SCImago, UGC-CARE List (India)
DARU Journal of Pharmaceutical Sciences is a peer-reviewed journal published on behalf of Tehran University of Medical Sciences. The journal encompasses all fields of the pharmaceutical sciences and presents timely research on all areas of drug conception, design, manufacture, classification and assessment.
The term DARU is derived from the Persian name meaning drug or medicine. This journal is a unique platform to improve the knowledge of researchers and scientists by publishing novel articles including basic and clinical investigations from members of the global scientific community in the forms of original articles, systematic or narrative reviews, meta-analyses, letters, and short communications.
As of Jan 2018 the journal is published as a hybrid journal (no article processing charges) by Springer. All articles published before 2017 are freely available on springerlink.
